But some experts have long warned that side effects of the drug — called donanemab — massively outweigh its benefits. Now, a new study from the company that produces the medication itself ...

A prodrug of galantamine and an acetylcholinesterase inhibitor (AChEI), benzgalantamine has a dual mechanism of action designed ... drugs lecanemab (Leqembi) and donanemab (Kisunla), galantamine ...

Today, the first monoclonal antibodies, lecanemab and donanemab, are available ... effects on cognition through multiple mechanisms of action, including an effect on amyloid and tau.